مجال
التميز
|
تميز دراسي و بحثي + جائزة تفوقية
|
|
|
البحوث المنشورة
|
|
البحث (1):
|
|
عنوان البحث:
|
How have Patients’ Experiences
of Cancer Care Been Linked to Survival? A Systematic Review
|
رابط إلى البحث:
|
Click here
|
تاريخ النشر:
|
23/04/2019
|
موجز عن البحث:
|
Patient experience of care remains an
important indicator of health care quality. Although studies show care
experiences are associated with health outcomes for some conditions, the
situation for cancer is unclear. New datasets on cancer patients in the US,
Canada, and UK linking information on experiences and survival may enable an
exploration of any association. This review aimed to identify studies linking
any aspect of cancer patients’ experiences to their survival, to inform
future analyses. We performed a systematic review using Medline database from
January 1998 until March 2018.
The settings included outpatient
oncology clinics, primary care, hospitals, and cancer centres. The
participants included adult patients from different demographic groups. 16
Studies (ten observational, two clinical trials, two qualitative, and two
consecutive case series) describing a wide range of settings, populations and
methods met our inclusion criteria. Patients’ experiences were mostly linked
to survival in quantitative studies. Satisfaction with care and psychosocial
support were the aspects of experience associated with survival. Although
positive associations between experience and survival were more common,
negative and lack of association findings were also reported. Overall, there
was no agreement on the strength, direction of the association, and the type
of measurements to use. In conclusion, a wide range of studies suggest a
relationship may exist between patients’ experiences of cancer care and their
survival. However, this relationship is complex and methodological
challenging to study. Future research should carefully consider different
aspects of patient experience and care and the way in which they may affect
cancer survival.
|
|
|
المؤتمرات العلمية:
|
|
المؤتمر (1):
|
|
عنوان المؤتمر:
|
Public
Health Research and Science Conference 2019
|
تاريخ الإنعقاد:
|
09/04/2019
|
مكان
الإنعقاد:
|
Manchester, UK
|
طبيعة المشاركة:
|
Oral presentation
|
عنوان المشاركة:
|
How representative are patients
responding to the CPES of the wider cancer population in England? Analyses
for breast, prostate, lung and colorectal cancer
|
ملخص المشاركة:
|
Background: The
National Cancer Patient Experience Survey (CPES) assesses English cancer
patients’ experiences of NHS care each year. Studies to date have used these
data to show systematic sociodemographic variations in cancer patients’
experiences. However, the extent to which the survey responders represent the
wider cancer patient population is not known. We examined how representative
CPES responders are of the wider cancer population in England with respect to
age, sex, socioeconomic status, ethnicity, and median survival for the most
common cancers.
Method: From the cancer registry, we
identified 103,186 colorectal, lung, breast and prostate cancer patients who
responded to at least one of the surveys carried out between 2010 and 2014.
In addition, for each CPES responder we randomly selected one patient who was
not a CPES responder based on their cancer site and time of diagnosis (same
yearly quarter).The distribution of the patient characteristics (age, sex,
socioeconomic status, ethnicity) and tumour characteristics (stage) were
compared between CPES responders and the cancer registry population using
chi-square test. We also compared median patients’ survival (in years)
between the two groups.
Results: Survey responders were younger,
more likely to be white, less deprived, and diagnosed with earlier disease
stage than the cancer registry population across all cancer types. Median
survival (in years) for the survey responders was higher than the cancer registry
population group across all cancers (colorectal: 4.8 vs 3.2; lung: 2.0 vs
0.3; breast: 5.7 vs 5.5; and prostate: 5.7 vs 5.2).
Conclusion: This
study showed that the representativeness of CPES results are limited in terms
of patient and tumour characteristics between different cancers. These
limitations need to be acknowledged when interpreting findings and future
surveys should consider adopting sampling methods to include the missing care
experiences of patients with lower survival, older age, and those from
different ethnic minorities.
|
الرابط:
|
Click here
|
|
|
المؤتمر (2):
|
|
عنوان المؤتمر:
|
Patient
Safety Forum 2019
|
تاريخ الإنعقاد:
|
22/04/2019
|
مكان
الإنعقاد:
|
Jeddah, KSA
|
طبيعة المشاركة:
|
POSTER PRESENTATION
|
عنوان المشاركة:
|
Comparison of the linked cancer
registry and cancer patient experience survey datasets in England and the
United States
|
ملخص المشاركة:
|
Background
Patient
care experience surveys are now used internationally to assess, monitor, and
improve healthcare quality. The National Cancer Patient Experience Survey
(CPES) is an annual English survey that invites patients to report their experiences
of National Health Service (NHS) cancer care. The Consumer Assessment of
Healthcare Providers and Systems(CAHPS) survey is widely used in the USA to
assess patients’ experiences of healthcare plans. Several years of collated
data for each survey have recently been linked to population-based cancer
registry data. We aimed to compare strengths and
weaknesses
of the datasets in order to consider the questions they may best answer.
Methods
We
obtained published information about both datasets, and compared data
sources, time period, patient age, cancer types, survey method and response
rate, linkage method, and question themes.
Results
The
English dataset of 233,445 patients was created by linking 2010-2014 national
CPES with cancer registry data by matching individual identifiers, whereas
the US dataset of 150,750 was created by first merging national Medicare data
with regional Surveillance Epidemiology with End Results (SEER) data and then
with all 1998-2010 CAHPS survey data. The major differences were that the US
dataset was largely limited to patients over the age of 65 years and included
a large non-cancer comparison group of 571,318 patients as well as data on
health costs. Both linkages included all cancer types, with breast, prostate,
colorectal, and lung cancer representing 50% of English and 61% of US
patients. Both were postal surveys, with non-respondents being followed up by
mail in England and by telephone in the USA. Response rates were similar in England
(67%) and the USA (71%). The questions themes were similar, with CPES
focussing on more cancer-specific experiences.
Conclusion
The
English dataset is likely to provide more detailed and representative data
answering questions about cancer experiences in the English population.
However, it may be possible to use both datasets to compare the experiences
of older patients receiving government-funded cancer care in each country.
The addition of economic data to English survey data as in the US data is an
intriguing avenue for future research. A translated version of CAPHS is being
used in Saudi Arabia, meaning that further data linkage and international
comparisons may be possible in due course.
|
الرابط:
|
Click here
|
|
|
جوائز التكريم :
|
|
الجائزة (1):
|
|
مسمى الجائزة:
|
Global
Experience Award
|
الجهة المانحة:
|
King’s College London
|
تاريخ الجائزة:
|
21/06/2019
|
مجال التكريم:
|
The Global Award is based on student
experiences. this is a great Award to focus a Study Abroad programme, learning
a language or volunteering with different communities locally or globally.
|
|
|
الجائزة (2):
|
|
مسمى الجائزة:
|
Global
Research Grant
|
الجهة المانحة:
|
King’s College London
|
تاريخ الجائزة:
|
20/05/2018
|
مجال التكريم:
|
This Global Research Grant (GRG) is
intended to provide a financial contribution to enable King’s research
mobility overseas. The GRG is also intended to develop and sustain research
partnerships with overseas organisations for King’s academics, research groups,
networks, departments, divisions and faculties.
The student won the grant to
visit the National Cancer Institute in the United States for 5 weeks, one of
the best and prestigious research centres in the world in cancer research
|